Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
CYTOKINETICS INC (CYTK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 144 Form 144 - Report of proposed sale of securities:
10/06/2023 4 Blum Robert I (President & CEO) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 12,500 shares @ $30, valued at $375k
Exercised 12,500 options to buy @ $6.67, valued at $83.4k
10/06/2023 8-K Other Events  Interactive Data
10/06/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 4 Harrington Robert Arthur (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 448 shares @ $27.88, valued at $12.5k
10/03/2023 4 HENDERSON JOHN T (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 762 shares @ $27.88, valued at $21.2k
10/03/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 448 shares @ $27.88, valued at $12.5k
10/03/2023 4 SMITH SANDFORD D (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 448 shares @ $27.88, valued at $12.5k
10/03/2023 4 WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 448 shares @ $27.88, valued at $12.5k
10/03/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 224 shares @ $27.88, valued at $6.2k
10/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description",
"Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description"
08/25/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 4 WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 6,020 shares @ $32.02, valued at $192.8k
Exercised 6,020 options to buy @ $6.72, valued at $40.5k
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 4 Blum Robert I (President & CEO) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 10,000 shares @ $43.924, valued at $439.2k
Sold 11,708 shares @ $32.3671, valued at $379k
Sold 792 shares @ $32.3671, valued at $25.6k
Exercised 10,000 options to buy @ $9.65, valued at $96.5k
Exercised 11,708 options to buy @ $9.65, valued at $113k
Exercised 792 options to buy @ $7.96, valued at $6.3k
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 4 Malik Fady Ibraham (EVP Research & Development) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 2,500 shares @ $31.7, valued at $79.3k
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "CYTOKINETICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS Completed Enrollment in SEQUOIA-HCM, Pivotal Phase 3 Trial of Aficamten in Obstructive HCM; On Track for Topline Results by the End of the Year Initiated Enrollment in MAPLE-HCM, a Phase 3 Clinical Trial Comparing Aficamten and Metoprolol in Obstructive HCM ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Non-Obstructive HCM, Expected to Start in September 2023 Company Reduces Projected Spending by Approximately 15% and Revises 2023 Financial Spending Guidance SOUTH SAN FRANCISCO, Calif., Aug. 3, 2023 -"
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 4 Blum Robert I (President & CEO) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 12,500 shares @ $35.2752, valued at $440.9k
Exercised 12,500 options to buy @ $9.65, valued at $120.6k
07/13/2023 4 Malik Fady Ibraham (EVP Research & Development) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 2,500 shares @ $35.37, valued at $88.4k
07/07/2023 144 Form 144 - Report of proposed sale of securities:
07/07/2023 4 Bhanji Muna (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 2,000 shares @ $34.1173, valued at $68.2k
07/05/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 187 shares @ $33.36, valued at $6.2k
07/05/2023 4 WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 374 shares @ $33.36, valued at $12.5k
07/05/2023 4 SMITH SANDFORD D (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 374 shares @ $33.36, valued at $12.5k
07/05/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 374 shares @ $33.36, valued at $12.5k
07/05/2023 4 HENDERSON JOHN T (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 636 shares @ $33.36, valued at $21.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy